Jeroen B. van Beek - 17 Feb 2021 Form 4 Insider Report for Allovir, Inc. (KLRS)

Signature
/s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol
KLRS
Transactions as of
17 Feb 2021
Net transactions value
-$1,409,646
Form type
4
Filing time
20 Sep 2021, 18:33:15 UTC
Next filing
01 Oct 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale $602,521 -15,196 -3% $39.65* 490,134 17 Feb 2021 Direct F1
transaction ALVR Common Stock Sale $19,420 -512 -0.11% $37.93* 472,522 02 Mar 2021 Direct F1, F2
transaction ALVR Common Stock Sale $346,583 -15,201 -3.2% $22.80* 457,321 18 May 2021 Direct F1
transaction ALVR Common Stock Sale $11,618 -508 -0.11% $22.87* 456,813 03 Jun 2021 Direct F1
transaction ALVR Common Stock Sale $270,953 -15,205 -3.3% $17.82* 441,608 17 Aug 2021 Direct F1
transaction ALVR Common Stock Sale $10,188 -513 -0.12% $19.86* 441,095 02 Sep 2021 Direct F1
transaction ALVR Common Stock Sale $148,362 -5,916 -1.3% $25.08* 435,179 17 Sep 2021 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock, and does not represent a discretionary trade by the reporting person.
F2 As previously reported, the reporting person sold 17,100 shares of Common Stock between February 17, 2021 and March 2, 2021.
F3 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2020.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.